Global  

FDA Pulls Emergency Authorization For Hydroxychloroquine

Video Credit: Wochit News - Duration: 00:37s - Published
FDA Pulls Emergency Authorization For Hydroxychloroquine

FDA Pulls Emergency Authorization For Hydroxychloroquine

It's the end of the road for a COVID-19 treatment once heralded as a “game changer” by Trump.

The FDA has revoked its emergency use authorization of hydroxychloroquine and chloroquine.

This is after a review of the evidence showed both drugs are likely ineffective against the virus.

Initially, doctors were allowed to prescribe it for COVID-19 despite it not being approved for that use.

Early studies suggested the drug could affect the coronavirus’s ability to replicate.


You Might Like


💡 One News Page Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

What is the ACIP? For a COVID vaccine to get cleared by the FDA, these 15 experts will vouch for its safety

Advisory Committee on Immunization Practices weighs crucial questions on the minds of millions: When can I get a COVID vaccine and will one be safe?

USATODAY.com

How long will it take for COVID-19 vaccine to be authorized? FDA Commissioner Stephen Hahn answers common questions

Food and Drug Administration Commissioner Dr. Stephen Hahn discussed the vaccine approval process and how the FDA will evaluate immunization safety.

USATODAY.com
COVID-19 Vaccine May Cause Flu-Like Symptoms [Video]

COVID-19 Vaccine May Cause Flu-Like Symptoms

Americans need to be prepared for the possibility that they may feel a little unwell. After you get a coronavirus vaccine, if one is authorized, you may experience some negative side effects. The CDC met to discuss whether to recommend the use of any Covid-19 vaccines. The US Food and Drug Administration or FDA is the agency that might authorize one. Volunteers in vaccine trials have reported they frequently feel flu-like effects after getting vaccinated.

Credit: Wochit News    Duration: 00:39Published

AstraZeneca vaccine brings more hope as hospitalizations soar

The AstraZeneca vaccine created with Oxford University is another sign of hope for the world as cases and hospitalizations run rampant. Dr. Amesh Adalja joins..
CBS News
Dow Jumps 210 Points On Vaccine News From AstraZeneca [Video]

Dow Jumps 210 Points On Vaccine News From AstraZeneca

On Monday, US stocks rose. AstraZeneca said its COVID-19 vaccine candidate demonstrated an average efficacy rate of 70%. This is the third COVID-19 vaccine said to have surpassed the Food and Drug Administration's requirement of 50% effectiveness. S&P 500: 3,580.82, up 0.7% Dow Jones industrial average: 29,473.41, up 0.7% (210 points) Nasdaq composite: 11,929.04, up 0.6%

Credit: Wochit News    Duration: 00:37Published

Donald Trump Donald Trump 45th president of the United States

US election: Trump 'congratulates' his country, doesn't mention concession

US President Donald Trump has made a brief statement from the White House, pointing out advances in Covid vaccines and hailing his country.The statement, less..
New Zealand Herald
In crucial electoral state Georgia's governor certifies Democrat win [Video]

In crucial electoral state Georgia's governor certifies Democrat win

It brings the state one step closer to wrapping up an election fraught with unfounded accusations of fraud by Trump and his supporters.

Credit: Euronews English    Duration: 01:20Published

US election: Biden certified as winning Pennsylvannia

Democrat Joe Biden was certified Tuesday as winner of the presidential election in Pennsylvania, culminating three weeks of vote counting and a string of failed..
New Zealand Herald

Facebook tweaked the News Feed to highlight more mainstream news sources for the election

Photo by Amelia Holowaty Krales / The Verge

Facebook, in the days after the US election, decided that an uptick in viral misinformation related to..

The Verge

GSA designates Joe Biden "apparent winner," enabling official transition

The General Services Administration has given President-elect Joe Biden the green light to begin the official transition process for his incoming administration...
CBS News

Related news from verified sources

FDA Revokes Emergency Authorization For Hydroxychloroquine To Treat COVID-19

The Food and Drug Administration revoked its emergency authorization for hydroxychloroquine as an...
RTTNews - Published Also reported by •TechCrunchNPRReutersDaily CallerCBS NewsMotley FoolNewsmax


Azar, Trump Mislead on FDA’s Hydroxychloroquine Decision

Azar, Trump Mislead on FDA’s Hydroxychloroquine Decision At the White House, the Health and Human Services secretary left the misleading impression that the...
FactCheck.org - Published

Hydroxychloroquine: FDA pulls emergency use of malaria drug touted by Trump to treat the coronavirus

The agency said Monday that the drugs hydroxychloroquine and chloroquine are unlikely to be effective...
USATODAY.com - Published Also reported by •ReutersNewsmax



Related videos from verified sources

Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo [Video]

Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo

President Donald Trump once touted hydroxychloroquine as “game changers” in the fight against the novel coronavirus COVID-19. Now, millions of doses of the drug are in limbo after the Food and..

Credit: Wochit     Duration: 00:36Published
FDA Withdraws Emergency Use Authorization For Hydroxychloroquine [Video]

FDA Withdraws Emergency Use Authorization For Hydroxychloroquine

The FDA has reversed course on hydroxychloroquine, KDKA's Dr. Maria Simbra reports.

Credit: KDKA CBS 2 Pittsburgh     Duration: 02:01Published
Trump Criticizes FDA Over Hydroxychloroquine Decision [Video]

Trump Criticizes FDA Over Hydroxychloroquine Decision

The U.S. FDA has revoked the emergency use authorization for hydroxychloroquine to treat COVID-19. According to Reuters, following the revocation, the FDA quickly came under fire from President Donald..

Credit: Wochit Tech     Duration: 00:32Published